Home

             UMLS 2025

10/10

D016609

We use MeSH codes primarily for indexing, cataloging, and searching biomedical literature.
MSH Medical Subject Headings The original, English version of the vocabulary.
MSHPOR Portuguese Portuguese MeSH headings.
MSHSPA Spanish (Decs) Spanish MeSH headings (often referenced as DeCS—Descriptors in Health Sciences).
MSHRUS Russian Russian MeSH headings.
MSHITA Italian Italian MeSH headings.
MSHGER German German MeSH headings.
MSHFRE French French MeSH headings.
MSHSWE Swedish Swedish MeSH headings.
MSHCZE Czech Czech MeSH headings.
MSHFIN Finnish Finnish MeSH headings.
MSHJPN Japanese Japanese MeSH headings.
MSHLAV Latvian Latvian MeSH headings.
MSHSCR Serbo-Croatian Serbo-Croatian MeSH headings.
MSHPOL Polish Polish MeSH headings.
MSHNOR Norwegian Norwegian MeSH headings.
MSHDUT Dutch Dutch MeSH headings.


Enter one or more words or parts of words

Click in last column to see ancestors descendants tree
Dict Code CUI Term Tree
Click on row column 3 or 4 for more information and multilingual
MSH D016609 C0085183 Malignancies, Second no pref
MSH D016609 C0085183 Malignancy, Second no pref
MSH D016609 C0085183 Neoplasm, Second no pref
MSH D016609 C0085183 Neoplasm, Second Primary preferred
MSH D016609 C0085183 Neoplasms, Second no pref
MSH D016609 C0085183 Neoplasms, Second Primary preferred
MSH D016609 C0085183 Second Malignancies no pref
MSH D016609 C0085183 Second Neoplasms no pref
MSH D016609 C0085183 Second Primary Neoplasm preferred
MSH D016609 C0085183 Metachronous Neoplasm no pref
MSH D016609 C0085183 Neoplasm, Metachronous no pref
MSH D016609 C0085183 SECOND NEOPL no pref
MSH D016609 C0085183 SECOND PRIMARY NEOPL no pref
MSH D016609 C0085183 NEOPL METACHRONOUS no pref
MSH D016609 C0085183 SECOND PRIMARY NEOPL METACHRONOUS no pref
MSH D016609 C0085183 METACHRONOUS SECOND PRIMARY NEOPL no pref
MSH D016609 C0085183 NEOPL SECOND PRIMARY no pref
MSH D016609 C0085183 NEOPL METACHRONOUS SECOND PRIMARY no pref
MSH D016609 C0085183 METACHRONOUS NEOPL no pref
MSHFIN D016609 C0085183 Toinen primaarikasvain preferred
MSHRUS D016609 C0085183 NOVOOBRAZOVANIIA, SVIAZANNYE S LECHENIEM no pref
MSHRUS D016609 C0085183 MALIGNIZATSIIA VTORICHNAIA no pref
MSHRUS D016609 C0085183 NOVOOBRAZOVANIIA VTORICHNO-PERVICHNYE no pref
MSHRUS D016609 C0085183 NOVOOBRAZOVANIE VTORICHNOE no pref
MSHRUS D016609 C0085183 VTORICHNO-PERVICHNYE NOVOOBRAZOVANIIA no pref
MSHRUS D016609 C0085183 NOVOOBRAZOVANIIA, TERAPIEI OBUSLOVLENNYE no pref
MSHJPN D016609 C0085183 腫瘍-異時性 no pref
MSHJPN D016609 C0085183 重複癌-異時性 no pref
MSHJPN D016609 C0085183 二次がん no pref
MSHJPN D016609 C0085183 二次癌 no pref
MSHJPN D016609 C0085183 腫瘍-治療関連性 no pref
MSHJPN D016609 C0085183 第二原発腫瘍 no pref
MSHJPN D016609 C0085183 異時性続発性原発癌 no pref
MSHJPN D016609 C0085183 異時性重複癌 no pref
MSHJPN D016609 C0085183 第二腫瘍 no pref
MSHJPN D016609 C0085183 治療関連性腫瘍 no pref
MSHJPN D016609 C0085183 癌-異時性続発性原発 no pref
MSHJPN D016609 C0085183 第二原発性腫瘍 no pref
MSHJPN D016609 C0085183 異時性腫瘍 no pref
MSHJPN D016609 C0085183 第二悪性 no pref
MSHJPN D016609 C0085183 腫瘍-第二原発 preferred
MSHJPN D016609 C0085183 腫瘍-治療関連 no pref
MSHJPN D016609 C0085183 治療関連腫瘍 no pref
MSHPOL D016609 C0085183 Nowotwory drugie no pref
MSHPOL D016609 C0085183 Nowotwory drugie pierwotne preferred
MSHPOL D016609 C0085183 Nowotwory metachroniczne no pref
MSHNOR D016609 C0085183 Sekundærsvulst preferred
MSHCZE D016609 C0085183 sekundární malignity preferred
MSHJPN D016609 C0085183 4重癌(異時性) no pref
MSHJPN D016609 C0085183 重複性癌(異時性) no pref
MSHJPN D016609 C0085183 多重がん(異時性) no pref
MSHJPN D016609 C0085183 重複がん(異時性) no pref
MSHJPN D016609 C0085183 三重癌(異時性) no pref
MSHJPN D016609 C0085183 3重癌(異時性) no pref
MSHJPN D016609 C0085183 多重癌(異時性) no pref
MSHJPN D016609 C0085183 四重癌(異時性) no pref
MSHJPN D016609 C0085183 重複癌(異時性) no pref
MSHJPN D016609 C0085183 重複癌(異時性)(チョウフクガン) no pref
MSHJPN D016609 C0085183 異時腫瘍(転移・再発以外) no pref
MSHJPN D016609 C0085183 二重癌(異時性) no pref
MSHJPN D016609 C0085183 腫瘍-異時(転移・再発以外) no pref
MSH D016609 C0085183 Second Neoplasm no pref
MSH D016609 C0085183 Metachronous Neoplasms no pref
MSH D016609 C0085183 Second Primary Neoplasms preferred
MSH D016609 C0085183 Metachronous Second Primary Neoplasms no pref
MSH D016609 C0085183 Second Malignancy no pref
MSH D016609 C0085183 Neoplasms, Metachronous no pref
MSH D016609 C0085183 Neoplasms, Metachronous Second Primary no pref
MSH D016609 C0085183 Second Primary Neoplasms, Metachronous no pref
MSHCZE D016609 C0085183 druhotné malignity no pref
MSHGER D016609 C0085183 Sekundärkarzinome no pref
MSHCZE D016609 C0085183 metachronní nádory no pref
MSHGER D016609 C0085183 Sekundäre Primär-Tumoren no pref
MSHGER D016609 C0085183 Tumoren, metachrone, sekundär-primäre no pref
MSHPOR D016609 C0085183 Segunda Neoplasia no pref
MSHCZE D016609 C0085183 duplicitní nádory no pref
MSHCZE D016609 C0085183 sekundární nádory no pref
MSHPOR D016609 C0085183 Segunda Malignidade no pref
MSHSPA D016609 C0085183 Neoplasia Secundaria no pref
MSHFRE D016609 C0085183 Seconde tumeur no pref
MSHFRE D016609 C0085183 Tumeur métachrone no pref
MSHGER D016609 C0085183 Sekundäre Malignität no pref
MSHPOR D016609 C0085183 Segunda Neoplasia Metacrônica Primária no pref
MSHGER D016609 C0085183 Sekundärtumor no pref
MSHPOR D016609 C0085183 Neoplasias Metacrônicas no pref
MSHGER D016609 C0085183 Tumoren, metachrone no pref
MSHCZE D016609 C0085183 nádory duplicitní no pref
MSHPOR D016609 C0085183 Segundas Neoplasias Primárias no pref
MSHCZE D016609 C0085183 sekundární malignita no pref
MSHSPA D016609 C0085183 Malignidad Secundaria no pref
MSHSPA D016609 C0085183 Neoplasias Metacrónicas Primarias Secundarias no pref
MSHSPA D016609 C0085183 Neoplasias Metacrónicas no pref
MSHSWE D016609 C0085183 Sekundära tumörer preferred
MSHFRE D016609 C0085183 Seconde tumeur primitive preferred
MSHGER D016609 C0085183 Tumoren, sekundäre Primär- preferred
MSHITA D016609 C0085183 Seconda neoplasia primaria preferred
MSHRUS D016609 C0085183 ВТОРИЧНО-ПЕРВИЧНЫЕ НОВООБРАЗОВАНИЯ no pref
MSHRUS D016609 C0085183 МАЛИГНИЗАЦИЯ ВТОРИЧНАЯ no pref
MSHRUS D016609 C0085183 НОВООБРАЗОВАНИЕ ВТОРИЧНОЕ no pref
MSHRUS D016609 C0085183 НОВООБРАЗОВАНИЯ ВТОРИЧНО-ПЕРВИЧНЫЕ preferred
MSHRUS D016609 C0085183 НОВООБРАЗОВАНИЯ, СВЯЗАННЫЕ С ЛЕЧЕНИЕМ no pref
MSHRUS D016609 C0085183 НОВООБРАЗОВАНИЯ, ТЕРАПИЕЙ ОБУСЛОВЛЕННЫЕ no pref
MSHDUT D016609 C0085183 Tumor, metachronische no pref
MSHDUT D016609 C0085183 Tumor, tweede primaire no pref
MSHDUT D016609 C0085183 Tumoren, tweede primaire no pref
MSHDUT D016609 C0085183 Tweede maligniteit no pref
MSHDUT D016609 C0085183 Tweede primaire tumor no pref
MSHDUT D016609 C0085183 Tweede primaire tumor no pref
MSHDUT D016609 C0085183 Tweede primaire tumoren no pref
MSHDUT D016609 C0085183 Tweede tumor preferred
MSHPOR D016609 C0085183 Segunda Neoplasia Primária preferred
MSHSPA D016609 C0085183 Neoplasias Primarias Secundarias preferred
MSH D016609 C0086696 Neoplasm, Therapy-Associated preferred
MSH D016609 C0086696 Neoplasm, Therapy-Related no pref
MSH D016609 C0086696 Neoplasm, Treatment-Associated no pref
MSH D016609 C0086696 Neoplasm, Treatment-Related no pref
MSH D016609 C0086696 Neoplasms, Therapy Associated preferred
MSH D016609 C0086696 Neoplasms, Therapy Related no pref
MSH D016609 C0086696 Neoplasms, Treatment Associated no pref
MSH D016609 C0086696 Neoplasms, Treatment Related no pref
MSH D016609 C0086696 Therapy Associated Neoplasms preferred
MSH D016609 C0086696 Therapy Related Neoplasms no pref
MSH D016609 C0086696 Therapy-Associated Neoplasm preferred
MSH D016609 C0086696 Therapy-Related Neoplasm no pref
MSH D016609 C0086696 Treatment Associated Neoplasms no pref
MSH D016609 C0086696 Treatment Related Neoplasms no pref
MSH D016609 C0086696 Treatment-Associated Neoplasm no pref
MSH D016609 C0086696 Treatment-Related Neoplasm no pref
MSH D016609 C0086696 TREATMENT RELAT NEOPL no pref
MSH D016609 C0086696 NEOPL TREATMENT ASSOC no pref
MSH D016609 C0086696 THER ASSOC NEOPL no pref
MSH D016609 C0086696 NEOPL THER ASSOC no pref
MSH D016609 C0086696 THER RELAT NEOPL no pref
MSH D016609 C0086696 NEOPL TREATMENT RELAT no pref
MSH D016609 C0086696 TREATMENT ASSOC NEOPL no pref
MSH D016609 C0086696 NEOPL THER RELAT no pref
MSHFRE D016609 C0086696 Tumeurs liées au traitement preferred
MSHGER D016609 C0086696 Therapieassoziierte Tumoren preferred
MSHNOR D016609 C0086696 Terapiassosierte svulster preferred
MSHSPA D016609 C0086696 Neoplasias Relacionadas con el Tratamiento preferred
MSHPOR D016609 C0086696 Neoplasias Relacionados ao Tratamento preferred
MSH D016609 C0086696 Neoplasms, Therapy-Associated preferred
MSH D016609 C0086696 Treatment-Related Neoplasms no pref
MSH D016609 C0086696 Treatment-Associated Neoplasms no pref
MSH D016609 C0086696 Therapy-Related Neoplasms no pref
MSH D016609 C0086696 Therapy-Associated Neoplasms preferred
MSH D016609 C0086696 Neoplasms, Therapy-Related no pref
MSH D016609 C0086696 Neoplasms, Treatment-Associated no pref
MSH D016609 C0086696 Neoplasms, Treatment-Related no pref
MSHSPA D016609 C0086696 Neoplasias Asociadas a Tratamiento no pref
MSHPOR D016609 C0086696 Neoplasias Associadas a Terapia no pref
MSHFRE D016609 C0086696 Tumeurs associées au traitement no pref
MSHNOR D016609 C0086696 Terapiassosierte tumorer no pref
MSHCZE D016609 C0086696 nádory spojené s terapií preferred
MSHPOR D016609 C0086696 Neoplasias Consequentes ao Tratamento no pref
MSHGER D016609 C0086696 Behandlungsassoziierte Tumoren no pref
MSHFRE D016609 C0086696 Tumeurs dues au traitement no pref
MSHGER D016609 C0086696 Tumoren, behandlungsbedingte no pref
MSHNOR D016609 C0086696 Terapiassosierte neoplasmer no pref
MSHGER D016609 C0086696 Tumoren, therapiebedingte no pref
MSHFRE D016609 C0086696 Tumeurs induites par le traitement no pref
MSHPOR D016609 C0086696 Neoplasias Associadas a Tratamento no pref
MSHSPA D016609 C0086696 Neoplasias Asociadas a Terapia no pref
MSHSPA D016609 C0086696 Neoplasias por Tratamiento no pref
MSHSWE D016609 C0086696 Terapiassocierade tumörer no pref
MSHSWE D016609 C0086696 Behandlingsassocierade tumörer preferred
MSHSWE D016609 C0086696 Behandlingsrelaterade tumörer no pref
MSHDUT D016609 C0086696 Behandelinggeassocieerde tumor no pref
MSHDUT D016609 C0086696 Therapiegeassocieerde tumor no pref
MSHDUT D016609 C0086696 Tumor, behandelinggerelateerde no pref
MSHDUT D016609 C0086696 Tumor, therapiegerelateerde preferred
MSHFRE D016609 C0751623 Second cancer primitif preferred
MSH D016609 C0751623 Cancers, Second Primary preferred
MSH D016609 C0751623 Second Primary Cancer preferred
MSH D016609 C0751623 Second Primary Cancers preferred
MSH D016609 C0751623 Cancer, Second no pref
MSH D016609 C0751623 Cancers, Second no pref
MSH D016609 C0751623 Second Cancers no pref
MSHCZE D016609 C0751623 sekundární rakovina preferred
MSHNOR D016609 C0751623 Sekundærkreft preferred
MSH D016609 C0751623 Cancer, Second Primary preferred
MSH D016609 C0751623 Second Cancer no pref
MSHFRE D016609 C0751623 Seconde tumeur maligne no pref
MSHFRE D016609 C0751623 Second cancer no pref
MSHSWE D016609 C0751623 Sekundär cancer preferred
MSH D016609 C0877578 THER RELAT CANCER no pref
MSH D016609 C0877578 THER ASSOC CANCER no pref
MSH D016609 C0877578 TREATMENT RELAT CANCER no pref
MSH D016609 C0877578 TREATMENT ASSOC CANCER no pref
MSHFRE D016609 C0877578 Cancer lié au traitement preferred
MSHGER D016609 C0877578 Therapieverbundener Krebs preferred
MSH D016609 C0877578 Cancer, Therapy-Associated no pref
MSH D016609 C0877578 Cancers, Therapy-Associated no pref
MSH D016609 C0877578 Therapy Associated Cancer no pref
MSH D016609 C0877578 Therapy-Associated Cancers no pref
MSH D016609 C0877578 Cancer, Treatment-Associated no pref
MSH D016609 C0877578 Cancers, Treatment-Associated no pref
MSH D016609 C0877578 Treatment Associated Cancer no pref
MSH D016609 C0877578 Treatment-Associated Cancers no pref
MSH D016609 C0877578 Cancer, Therapy-Related no pref
MSH D016609 C0877578 Cancers, Therapy-Related no pref
MSH D016609 C0877578 Therapy Related Cancer no pref
MSH D016609 C0877578 Therapy-Related Cancers no pref
MSH D016609 C0877578 Cancer, Treatment-Related no pref
MSH D016609 C0877578 Cancers, Treatment-Related no pref
MSH D016609 C0877578 Treatment Related Cancer no pref
MSH D016609 C0877578 Treatment-Related Cancers no pref
MSHNOR D016609 C0877578 Terapiassosiert kreft preferred
MSHPOR D016609 C0877578 Câncer Relacionado a Terapia preferred
MSHSPA D016609 C0877578 Neoplasias Relacionadas con la Terapia preferred
MSH D016609 C0877578 Therapy-Associated Cancer no pref
MSH D016609 C0877578 Treatment-Related Cancer no pref
MSH D016609 C0877578 Therapy-Related Cancer no pref
MSH D016609 C0877578 Treatment-Associated Cancer no pref
MSHGER D016609 C0877578 Behandlungsverbundener Krebs no pref
MSHCZE D016609 C0877578 rakovina spojená s terapií preferred
MSHFRE D016609 C0877578 Cancer induit par le traitement no pref
MSHFRE D016609 C0877578 Cancer associé au traitement no pref
MSHFRE D016609 C0877578 Cancer secondaire au traitement no pref
MSHPOR D016609 C0877578 Câncer Relacionado a Tratamento no pref
MSHSPA D016609 C0877578 Neoplasias Relacionadas a Tratamiento no pref
MSHSWE D016609 C0877578 Terapirelaterad cancer no pref
MSHSWE D016609 C0877578 Behandlingsrelaterad cancer preferred
MSHDUT D016609 C0877578 Behandelinggerelateerde tumor no pref
MSHDUT D016609 C0877578 Therapiegerelateerde tumor preferred
D016609








Read more: https://www.nlm.nih.gov/research/umls/sourcereleasedocs/


Web development by Gayane Margaryan